Table 2 Disease-related characteristics in gout patients

 Hypertension

96 (42.5)

 DM

23 (10.2)

 Hyperlipidemia

25 (11.1)

 Cardiovascular disease

22 (9.7)

 Nephropathy

17 (7.5)

 Disease duration (year)^C

5 (2–12)

 Number of flares/last year^C

3 (1.25–12)

 Asymptomatic (hyperuricemia)

8 (3.5)

 Acute phase

128 (56.6)

 Intercritical phase

37 (16.4)

 Chronic phase

53 (23.5)

 No

136 (60.2)

 1

37 (16.4)

  ≥ 2

53 (23.5)

sUA (μmol/L)^a

468.15 ± 116.59

Presence of tender joints, yes^b

190 (84.1)

Presence of swollen joints, yes^b

162 (71.7)

Total pain (VAS)^C

4.25(0–7.75)

 Allopurinol

16 (7.1)

 Febuxostat

80 (35.4)

 Colchicine

146 (64.6)

 NSAID

105 (46.5)

 Corticosteroids

71 (31.4)